Suppr超能文献

靶向肝激酶 B1促进成年中枢神经系统轴突再生。

Promoting Axon Regeneration in Adult CNS by Targeting Liver Kinase B1.

机构信息

Shriners Hospitals Pediatric Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA; Department of Anatomy and Cell Biology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.

Shriners Hospitals Pediatric Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA; Department of Neuroscience, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.

出版信息

Mol Ther. 2019 Jan 2;27(1):102-117. doi: 10.1016/j.ymthe.2018.10.019. Epub 2018 Nov 1.

Abstract

Liver kinase B1 (LKB1), a downstream effector of cyclic AMP (cAMP)/PKA and phosphatidylinositol 3-kinase (PI3K) pathways, is a determinant for migration and differentiation of many cells, but its role in CNS axon regeneration is unknown. Therefore, LKB1 was overexpressed in sensorimotor cortex of adult mice five days after mid-thoracic spinal cord injury, using an AAV2 vector. Regeneration of corticospinal axons was dramatically enhanced. Next, systemic injection of a mutant-AAV9 vector was used to upregulate LKB1 specifically in neurons. This promoted long-distance regeneration of injured corticospinal fibers into caudal spinal cord in adult mice and regrowth of descending serotonergic and tyrosine hydroxylase immunoreactive axons. Either intracortical or systemic viral delivery of LKB1 significantly improved recovery of locomotor functions in adult mice with spinal cord injury. Moreover, we demonstrated that LKB1 used AMPKα, NUAK1, and ERK as the downstream effectors in the cortex of adult mice. Thus, LKB1 may be a critical factor for enhancing the growth capacity of mature neurons and may be an important molecular target in the treatment of CNS injuries.

摘要

肝激酶 B1(LKB1)是环磷酸腺苷(cAMP)/蛋白激酶 A(PKA)和磷脂酰肌醇 3-激酶(PI3K)通路的下游效应物,是许多细胞迁移和分化的决定因素,但它在中枢神经系统(CNS)轴突再生中的作用尚不清楚。因此,在中胸段脊髓损伤后 5 天,通过 AAV2 载体在成年小鼠感觉运动皮层中过表达 LKB1。皮质脊髓轴突的再生明显增强。接下来,使用突变型 AAV9 载体进行全身注射,以特异性上调神经元中的 LKB1。这促进了损伤的皮质脊髓纤维在成年小鼠中的长距离再生,以及下行 5-羟色胺能和酪氨酸羟化酶免疫反应性轴突的再生。在成年脊髓损伤小鼠中,LKB1 的皮质内或全身病毒传递均显著改善了运动功能的恢复。此外,我们证明 LKB1 在成年小鼠的皮层中使用 AMPKα、NUAK1 和 ERK 作为下游效应物。因此,LKB1 可能是增强成熟神经元生长能力的关键因素,并且可能是 CNS 损伤治疗中的重要分子靶标。

相似文献

引用本文的文献

4
Advances in molecular therapies for targeting pathophysiology in spinal cord injury.脊髓损伤病理生理学靶向的分子治疗进展。
Expert Opin Ther Targets. 2023 Mar;27(3):171-187. doi: 10.1080/14728222.2023.2194532. Epub 2023 Apr 5.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验